期刊文献+

肝细胞癌及癌旁组织中骨形态发生蛋白的免疫组织化学研究 被引量:2

The Study on Bone Morphogenetic Proteins in Hepatocellular Carcinomas and Their Surrounding Liver Tissues By Using Immunohistochemistry
原文传递
导出
摘要 目的 研究HCC及其癌旁组织是否存在BMPs。方法 利用S -P免疫组织化学技术检测 15例肝细胞癌及其癌旁组织中BMPs的表达。结果 BMPs不均一的存在于HCC及其癌旁组织中。肝癌细胞胞浆和 /或胞核呈阳性 ,而癌旁组织胞浆阳性 ,仅一例胞浆胞核阳性。结论 首次报道肝细胞癌及其癌旁组织存在骨形态发生蛋白BMPs 。 Objective To study whether BMPs exist in HCC and their surrounding liver tissues. Methods S-P immunohistochemistry was used to detect the expression of BMPs in 15 HCC and their surrounding liver tissues. Results We found that the positive singnals of BMPs were heterogeneous localized in nucleuses and/or cytoplasm in hepatocarcinoma cells, and pericarcinomatous tissues were mainly stained in cytoplasmic. BMP positive in both nucleuses and cytoplasma was seen only one case.Conclusion BMPs exist in HCC and their surrounding tissues and might be related to the carcinogenesis of HCC.
出处 《中国医师杂志》 CAS 2002年第4期378-380,共3页 Journal of Chinese Physician
关键词 骨形态发生蛋白 肝细胞癌 癌旁组织 免疫组织化学 Bone morphogenetic proteins Hepatocellular carcinomas Pericarcinomatous tissue Immunohistochemistry
  • 相关文献

参考文献5

二级参考文献10

  • 1金岩,国外医学口腔医学分册,1988年,15卷,2期,81页
  • 2杨连甲,实用口腔医学杂志,1987年,3卷,2期,78页
  • 3樊代明,上海免疫学杂志
  • 4樊代明,第四军医大学学报,1989年,10卷,215页
  • 5金岩,国外医学口腔医学分册,1988年,15卷,81页
  • 6杨连甲,实用口腔医学,1987年,3卷,78页
  • 7Hsu S M,J Histochem Cytochem,1981年,29卷,577页
  • 8Zhao M,J Oral Pathol Med,1998年,27卷,293页
  • 9Yang L J,Virch Arch A(Pathol Anat),1993年,422卷,439页
  • 10Jin Y,Clin Orthop,1990年,259卷,233页

共引文献20

同被引文献27

  • 1章翔,吴景文,李侠,付洛安,高大宽,白红民,刘先珍.人骨形成蛋白-2和透明质酸对脑胶质细胞瘤侵袭性的影响[J].中华医学杂志,2002,82(2):90-93. 被引量:6
  • 2Cui-Ping Xu,Wen-Min Ji,Gijs R van den Brink,Maikel P Peppelenbosch.Bone morphogenetic protein-2 is a negative regulator of hepatocyte proliferation downregulated in the regenerating liver[J].World Journal of Gastroenterology,2006,12(47):7621-7625. 被引量:10
  • 3李秀青,王琦.肝癌中骨形成蛋白2对PTEN蛋白水平影响的研究[J].中国药物与临床,2007,7(1):24-26. 被引量:7
  • 4Buckley S,Shi W,Drisoll B,et al.BMP4 signaling induces senescence and modulates the ogenic phenotype of A549 lung adenocarcinoma cells [J].Am J Physiol,2004,286(1):L81~L86.
  • 5Langenfeld EM,Calvano SE,Abou-Nukta F,et al.The mature bone morphogenetic protein-2 is aberrantly expressed in non-small cell lung carcinomas and stimulates tumor growth of A549 cells[J].Carcinogenesis,2003,24(9):1445~1454.
  • 6Kim JS,Crooks H,Dracheva T,et al .Oncogenic β-catenin is required for bone morphogenetic protein-4 expression in human cancer cells[J].Cancer Res,2002,62(10):2744~2748.
  • 7Kimura N,Matsuo R,Shibuya H,et al.BMP2 induced apoptosis is mediated by activation of the TAK1-p38 kinase pathway that is negatively regulated by Smad[J].J Biol Chem,2000,275 (23):17647~17652.
  • 8Ghosh-Chouhury N,Ghosh-Choudhury G,Celeste A,et al.Bone mophogenetic protein-2 induces cyclin kinase inhibitor p21 and hypophosphorylation of retinoblastoma protein in estraiol-treated MCF-7 human breast cancer cells[J].Biochem Biophys Acta,2000,1497(2):186~196.
  • 9Reinholz MM,Iturria SJ,Ingle JN,et al.Differential gene expression of TGF-β family members and osteopontin in breast tumor tissue:analysis by read-time quantitative PCR[J].Breast Cancer Res Treast,2002,74(3):255~269.
  • 10Pouliot F,Labrie C.Role of Smad1 and Smad4 in the induction of p21 WAF1,Cip1 during bone morphogenetic protein-induced growth in human breast cancer cells[J].J Endocrinol,2002,172(1):187~198.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部